Checking glucose monitor accuracy during pregnancy
Part of Hormones & metabolism clinical trials.
This trial tests how accurate two different continuous glucose monitors (CGMs) are during pregnancy, to help improve diabetes care for pregnant women. By wearing two sensors, they can compare readings and see if they are reliable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have type 1, type 2, or gestational diabetes that was diagnosed before 32 weeks of pregnancy.
- You are 18 years old or older.
- You are willing to wear two continuous glucose monitors (CGMs) at the same time.
- You have a smartphone that works with the LibreLink app.
- You can give your informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study compares using a continuous glucose monitor (a small sensor that tracks sugar levels all day) with the usual finger-prick testing in women with gestational diabetes. The goal is to see if the monitor helps control blood sugar better and is easier to use.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This study tests whether using a continuous glucose monitor during pregnancy is useful for people with type 2 diabetes. It may help track blood sugar levels more closely to support safer pregnancy care.
This trial tests whether using a continuous glucose monitor (CGM) during pregnancy and after delivery helps women with gestational diabetes. It aims to see if the Dexcom G7 can improve health outcomes for both you and your baby.
Hear when a new Pregestational Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.